MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Bruker Corporation
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bruker Announces Acquisition of Canopy Biosciences, LLC - Strengthens Bruker in Targeted Multi-Omics and High-Plex Biomarker Imaging Adds Innovative ChipCytometry Tools for Multi-Dimensional Immune Profiling - CanopyBiosciences.com / Bruker.com
Bruker Announces Acquisition of Canopy Biosciences, LLC

 

NewswireToday - /newswire/ - Billerica, MA, United States, 2020/09/11 - Strengthens Bruker in Targeted Multi-Omics and High-Plex Biomarker Imaging Adds Innovative ChipCytometry Tools for Multi-Dimensional Immune Profiling - CanopyBiosciences.com / Bruker.com. NASDAQ: BRKR

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Electronics / Instrumentation / RFID Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Bruker Corporation today announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell therapy. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques. Bruker’s global reach, complementary technologies and applications knowledge will help build on Canopy’s success to date. Financial details of the transaction were not disclosed.

“We are excited to add the multi-omics and high-content cytometry expertise of Canopy, and its novel ChipCytometry platform to Bruker,” said Dr. Mark R. Munch, the Bruker NANO Group President. “Canopy has a unique set of products that enable single cell, tissue and suspended cell-based discovery and validation in immunology and targeted proteomics, as well as a suite of complementary multi-omics services.”

“We are very pleased to join Bruker,” added Dr. Edward Weinstein, the CEO of Canopy Biosciences. “Joining forces with a leading life-science tools provider with broad geographic reach enables us to give many more researchers access to our powerful high-plex ChipCytometry platform, designed for accelerating basic immunology and clinical research, as well as biopharma drug development.”

“Canopy has built a powerful suite of multi-omics technologies,” explained Dr. Frank Witney, Operating Partner of Ampersand Capital Partners, the lead Canopy investor. “Joining Bruker will strengthen and deepen this platform, enabling researchers to better answer their scientific and translational questions with unprecedented power and precision.”

About Bruker Corporation

Bruker (bruker.com) is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.

About Canopy Biosciences, LLC

Canopy Biosciences (canopybiosciences.com) was formed in 2016 and has rapidly built a comprehensive portfolio of products and services for gene editing, gene expression analysis and regulation, and bioprocessing. Canopy’s gene editing portfolio offers easy-to-use CRISPR kits and full-service custom cell line engineering. Canopy has also assembled an innovative multi-omic platform for immune profiling, including ultrasensitive DNA sequencing (RareSeq), RNAseq, gene expression analysis, and multiplexed protein detection in cells and tissue samples via ChipCytometry. Canopy Biosciences is headquartered in St. Louis, Missouri, and serves researchers at universities, research institutions and biotechnology and pharmaceutical companies worldwide. Additional information is available at canopybiosciences.com. Its subsidiary ZELLKRAFTWERK GmbH (zellkraftwerk.com) in Leipzig, Germany, designs and manufactures high-plex ChipCytometry platforms and complete workflows for high-content cytometry on cells and tissues.

About Ampersand Capital Partners

Founded in 1988, Ampersand (ampersandcapital.com) is a middle market private equity firm dedicated to growth-oriented investments in the healthcare sector. With offices in Boston and Amsterdam, Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of our core healthcare sectors, including Brammer Bio, Confluent Medical, Genewiz, Genoptix, Talecris Biotherapeutics, and Viracor-IBT Laboratories.

Forward Looking Statements for Bruker Corporation

Any statements contained in this press release related to Bruker, Canopy Biosciences, LLC and the acquisition of Canopy Biosciences, LLC by Bruker which do not describe historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by qualifiers such as “expect,” “anticipate,” “will,” and similar expressions. Any forward-looking statements contained in this press release are based on Bruker’s current expectations, but are subject to risks and uncertainties that could cause actual results to differ materially from those indicated. Forward-looking statements in this communication include, among other things, statements about the potential benefits of the transaction, Bruker’s plans, objectives, expectations and intentions, and the financial condition, results of operations and business of Bruker following the completion of the proposed transaction. Risks and uncertainties include, among other things, risks and uncertainties relating to the consummation of the proposed acquisition on the proposed terms and schedule; Bruker’s financial and operational performance following the completion of the proposed transaction; Bruker’s ability to successfully integrate the business and realize the strategic and other benefits of the acquisition; the timing of when the acquisition will be accretive to earnings; and other risk factors identified and described in Bruker’s filings with the Securities and Exchange Commission, including, without limitation, Bruker’s annual report on Form 10-K for the year ended December 31, 2019 and subsequently filed Quarterly Reports on Form 10-Q. Bruker expressly disclaims any intent or obligation to update these forward-looking statements other than as required by law.

Investor Contact: Miroslava Minkova - Director, Investor Relations & Corporate Development
T: +1 978-663-3660 x1479 - E: Investor.Relations[.]bruker.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Electronics / Instrumentation / RFID Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Bruker Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Electronics / Instrumentation / RFID articles,
CATCH Visitors via Your Competitors Announcements!


Bruker Announces Acquisition of Canopy Biosciences, LLC

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Stephen Hopkins - Bruker.com 
520-741-1044 x1022 steve.hopkins[.]bruker.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bruker Corporation securities in any jurisdiction including any other companies listed or named in this release.

Electronics / Instrumentation / RFID via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bruker Corporation / Company Profile


Read Electronics / Instrumentation / RFID Most Recent Related Newswires:

Eurotech Announces CPU-161-19 - A COM Express Module with Intel Atom X6000 Series
Bruker Launches Advanced In-Situ Nanomechanical Test Instrument for Analyzing Materials Deformation in Electron Microscopes
Curtiss-Wright Defense Solutions Establishes MOSA Task Force to Drive Solutions Developed in Alignment with CMOSS and the SOSA™ Technical Standard
Datalogic Unveils Faster and More Accurate Inventory with the New Powerful 2128P RFID Sled
Detego and Microsoft Collaborate to Fast-track Development of the Most Advanced RFID Platform in the Retail Industry
Bruker Announced Licence Agreement with Oxford Instruments Regarding Cube
Imec Demonstrates CNT Pellicle Utilization on EUV Scanner
Bruker Announces Acquisition of Integrated Proteomics Pipeline (IP2) Software Platform for Large Cohort Translational Studies
Sensata Technologies Introduces High Accuracy Hermetic Pressure Sensors for Industrial Applications
Smart Sensor Devices Announces its New Distribution Agreement with Verical
Bruker Releases Suite of Benchtop 3D Optical Profiler Systems
Datalogic Launches the New PDA Memor™ K - A Powerful, Pocketable Companion for any Data Capture Application
Kontron COM Express® and SMARC Module with Next Generation Low-power Intel Atom Processors
Curtiss-Wright Defense Solutions to Expand Position in Tactical and Enterprise Network Communications Systems Markets with Acquisition of Pacific Star
Kontron Deploys 11th Gen Intel Core Processors on COM Express® Modules, 3U VPX Blades and 3.5' SBC

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  RightITnow, Inc.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)